The cost of insulin has been an issue discussed by lawmakers at the state level. It’s also an issue that has caught the attention of federal lawmakers according to Minnesota Senator Tina Smith.
“Included in the end of the year bills are several proposals to increase the availability of generic insulin and to increase competition,” said Smith. “I think people will notice that and it will be helpful.”
The measure was included in a larger appropriations bill that was approved by the US House and Senate and signed by President Trump last week.